Descripción del proyecto
AlzhUp is the first social-health digital service fighting against Alzheimer’s focused on delaying cognitive impairment and help in active ageing, increasing QoL of patients, caregivers and families.
AlzhUp is based on the use of Non Pharmacological Therapies, scientifically validated by the Spanish Ministry of Health and CRE Alzheimer after 2 years of scientific research with more than 150 users, combined with a Personal Bank of Memories that uses own memories with a special algorithm simulating brain behaviour and with gamification techniques to improve Active Participation of family and using current technology as a vehicle to offer an accessible service.
España [Comunidad de Madrid]
Fecha de comienzo
Coste estimado del proyecto
10 millones de euros
Digital, incluidos los contenidos y servicios digitales
Titularidad de los activos
Tipo de proyecto
Estado del proyecto
Tipo de ingresos
Subscription, doctor referral, training
Justificación económica / modelo empresarial
- Technical development: 2 M€ next 3 years,
- Scientific validation FDA in USA: 3 M€ next 2 years,
- Investment in User Acquisition B2C model: 3.5 M€ next 3 years,
- Business Development LATAM & Asia: 1.5 M€ next 3 years.
We are a global company, with a subsidiary established in Miami to face the USA market (commercial office), although all the project are being developed in Europe (Spain)
Detalles de la financiación
Financiación del proyecto garantizada: 1 millones de euros (10 %)
Contribución propia: 1 millones de euros (10 %)
Fuente de financiación: Privada
Reta al Alzheimer has already secured and investment 800.000 € and have partners in USA who can support up to 2 M€.
El promotor ha solicitado o tiene intención de solicitar financiación de la UE o del BEI en relación con este proyecto
Obstáculos existentes o potenciales para la realización del proyecto / Riesgos potenciales
Attraction of users: disseminated market, fed up of non working solutions for Alzheimer’s.
Scientific Claims: we have a scientific validation in place for AlzhUp thanks to CRE Salamanca in Spain, and we need our clinical trials of AlzhUp in USA to demonstrate our effectiveness and position our service.
Penetration into other markets: we will require specific needs of each market in order to properly adapt AlzhUp, that is the reason to gather the correct knowledge and partners we need.
Información adicional sobre el proyecto
Reta al Alzheimer has managed by its own means to fufill the first phase of its big vision, creating the first version of its service, conducting clinical trials, validating the core science of the company, managing to gather partners externally and also signing its first contract in the B2B market. In order to continue an exponential growth and fulfill its second stage (gathering millions of users affected by Alzheimer’s in different locations), we need a huge investment. AlzhUp is not just an ICT company, nor a full Biological one, but the mix of both sides which demands high investment but with very profitability results.
La Comisión no ofrece ninguna garantía y no está facultada para manifestar, ni expresa ni implícitamente, que la información del proyecto está libre de error. La información del proyecto se ofrece sin ningún tipo de garantías o condiciones en cuanto a su exactitud.
A free translation into English has been provided by the European Commission on this project, for information purposes only. The original language version is the authentic version.